TOKYO, Japan, October 15, 2024 — CarbGeM Inc, a Japan-based startup focused on AI-based diagnostics, and The University of Zurich, today announced collaborative research initiative focusing on bacterial persistence among ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriacae species) and other bacteria. CarbGeM’s measurement technology is central to the experimental setup, enabling precise and detailed analysis of bacterial growth dynamics and the identification of potential persister cells within the context of antibiotic exposure.
In this collaboration, clinical isolates from the Institute of Medical Microbiology of the University of Zurich will be tested using CarbGeM’s Bacterial Growth Monitor System which enables real-time monitoring of bacterial growth and generates a wealth of data, supporting comprehensive analyses and the potential discovery of novel insights into bacterial persistence.
The University of Zurich (UZH) is a member of the League of European Research Universities and number is among Europe’s most prestigious research institutions. UZH’s international standing is reflected in the many renowned academic distinctions conferred upon its members, including twelve Nobel Prizes. As Switzerland’s largest university, UZH has a current enrollment of over 26,000 students and offers the most comprehensive academic program in the country. Over 5,000 excellent members of staff teach and perform research at one of the University’s 150 departments, including over 500 professors. UZH also looks back on a rich history, having been founded in 1833 as Europe’s first university to be established by a democratic political system. For more information please visit www.uzh.ch
By the fusion of biology and digital technology, CarbGeM aims to apply its uniquely developed diagnostic technology to the bacterial infection field. In addition, CarbGeM is trying to solve the global issue of antimicrobial resistance (AMR) through collaborations with world-leading hospitals, universities, and companies.
・Headquarters location: 1-5-13, Jinnan, Shibuya-ku, Tokyo
・CEO: Masakazu Nakajima
・URL： https://carbgem.com/en/
